CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF)

NACompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

August 31, 2019

Study Completion Date

October 31, 2023

Conditions
Persistent Atrial Fibrillation
Interventions
DEVICE

AtriCure EPi-Sense-AF Guided Coagulation System with VisiTrax

Convergent Epicardial Endocardial Ablation Procedure

DEVICE

Endocardial RF Catheter ablation using Open Irrigated-tip RF Abaltion Catheter with unidirectional or bidirectional steering

Endocardial Catheter Ablation Procedure

Trial Locations (27)

10305

Staten Island University Hospital, Staten Island

11219

Maimonides Medical Center, Brooklyn

15212

Allegheny-Singer Research Institute, Pittsburgh

17101

UPMC Pinnacle Hospitals, Harrisburg

20010

Medstar Washington Hospital Center, Washington D.C.

23229

Virginia Cardiovascular Specialists, Richmond

27518

Wake Medical Center / Cary Research Group, Raleigh

27710

Duke University Medical Center, Durham

27834

East Carolina University - Vidant Medical Center, Greenville

30342

Emory University - St. Joseph's Hospital, Atlanta

32204

St. Vincent's HealthCare, Jacksonville

33140

Mt Sinai Medical Center, Miami Beach

33410

Palm Beach Gardens Medical Center, Palm Beach Gardens

35243

Grandview Medical Center, Birmingham

35801

Heart Center Research LLC, Huntsville

38801

Cardiology Associates Research, LLC, Tupelo

43214

Riverside Hospital / OhioHealth, Columbus

44304

Summa Health System, Akron

46260

St. Vincent Medical Group Inc., Indianapolis

48439

Genesys Regional Medical Center, Grand Blanc

70808

Cardiovascular Research Foundation of Louisiana, Baton Rouge

78229

STAR Clinical Trials LLC, San Antonio

78756

Austin Heart PLLC, Austin

80220

Rose Medical Center / Medical Center of Aurora, Denver

01805

Lahey Clinic, Burlington

E1 1BB

St. Bartholomew's Hospital, London

SE1 7EH

Guy's and St. Thomas Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AtriCure, Inc.

INDUSTRY

NCT01984346 - CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF) | Biotech Hunter | Biotech Hunter